17
Participants
Start Date
February 28, 2003
Primary Completion Date
June 30, 2011
Study Completion Date
October 31, 2011
"Human recombinant leptin (metreleptin)"
Metreleptin was administered at a dose of 0.02 mg / kg body weight for two months, followed by a dose of 0.04 mg / kg for two more months.
Placebo
Placebo was administered at a dose of 0.02 mg / kg body weight daily by subcutaneous injection for two months, followed by 0.04 mg / kg for two more months.
Baylor College of Medicine, Houston
Baylor College of Medicine
OTHER